Omid Hamid, MD, discusses the investigation of the LAG-3 inhibitor fianlimab in combination with cemiplimab in patients with advanced melanoma who were naïve to anti–PD-1 agents in the advanced setting.
Ryan J. Sullivan, MD, discusses previous research on tebentafusp in uveal melanoma that led to the inception of the IMCgp100-202 trial and clinical implications for data confirming the predictive value of circulating tumor DNA levels.
After learning that a red spot under her eye was innocuous, Christy Staats believed her nightmare was over. But, a dermatologist at a Portland research university found another troubling spot on her right cheek during the examination, which turned out to be melanoma, the world s smallest skin cancer